MorphoSys (MOR) News Today

€67.70
-0.05 (-0.07%)
(As of 04/24/2024 ET)
SourceHeadline
finance.yahoo.com logoMorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
finance.yahoo.com - April 24 at 12:17 PM
marketbeat.com logoMorphoSys (ETR:MOR) Reaches New 12-Month High at $68.00
marketbeat.com - April 17 at 7:36 PM
msn.com logoGerman biopharma MorphoSys recommends Novartis offer be accepted
msn.com - April 11 at 5:48 PM
finanznachrichten.de logoNovartis Pharma AG: Novartis tender offer for MorphoSys AG commences
finanznachrichten.de - April 11 at 7:47 AM
finance.yahoo.com logoNovartis tender offer for MorphoSys AG commences
finance.yahoo.com - April 11 at 7:47 AM
msn.com logoNovartis commences tender offer for MorphoSys
msn.com - April 11 at 7:47 AM
msn.com logoNovartis begins tender offer for cancer-focused MorphoSys
msn.com - April 11 at 7:47 AM
finance.yahoo.com logoUPDATE 2-Novartis begins tender offer for cancer-focused MorphoSys
finance.yahoo.com - April 11 at 7:47 AM
seekingalpha.com logoNovartis: Higher Guidance, Now A Buy
seekingalpha.com - April 4 at 3:32 AM
marketbeat.com logoMorphoSys (ETR:MOR) Sets New 52-Week High at $67.30
marketbeat.com - April 2 at 7:48 PM
markets.businessinsider.com logoEQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
markets.businessinsider.com - March 22 at 7:54 AM
finance.yahoo.com logoMorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 15 at 1:28 PM
markets.businessinsider.com logoEQS-News: MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
markets.businessinsider.com - March 13 at 6:55 PM
benzinga.com logoMorphoSys: Q4 Earnings Insights
benzinga.com - March 13 at 6:55 PM
msn.com logoGerman regulators approve Novartis deal to buy drugmaker Morphosys
msn.com - March 12 at 9:48 AM
finance.yahoo.com logoWhat Makes MorphoSys AG Unsponsored ADR (MOR) a Strong Momentum Stock: Buy Now?
finance.yahoo.com - February 15 at 3:09 PM
finance.yahoo.com logoBiotech Stock Roundup: GILD, AMGN & BMY's Q4 Results, MOR Up on NVS Deal & More
finance.yahoo.com - February 8 at 2:17 PM
realmoney.thestreet.com logoMorphoSys just downgraded at JMP Securities, here's why
realmoney.thestreet.com - February 7 at 2:39 AM
finance.yahoo.com logoNovartis (NVS) to Buy MorphoSys & Add Late-Stage Oncology Drug
finance.yahoo.com - February 6 at 3:20 PM
seekingalpha.com logoNovartis And MorphoSys Are A Perfect Match
seekingalpha.com - February 6 at 10:20 AM
finance.yahoo.com logoNovartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash
finance.yahoo.com - February 5 at 6:41 PM
finance.yahoo.com logoUPDATE 1-Novartis to acquire cancer drug developer MorphoSys for $2.9 bln
finance.yahoo.com - February 5 at 6:41 PM
morningstar.com logoMorphoSys AG ADR MOR
morningstar.com - February 3 at 6:26 PM
markets.businessinsider.com logoDAX Edges Higher As Investors Await GDP Data
markets.businessinsider.com - January 31 at 7:45 PM
marketwatch.com logoUS Futures Flat, European Stocks Slightly Down Ahead of Central Bank Decisions
marketwatch.com - January 30 at 5:51 PM
markets.businessinsider.com logoEuropean Shares Slightly Higher; Flash Eurozone GDP Data Awaited
markets.businessinsider.com - January 30 at 5:51 PM
msn.com logoMorphoSys expects 2024 Monjuvi U.S. net product sales in $80M - $95M range
msn.com - January 30 at 8:28 AM
finance.yahoo.com logoMorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability
finance.yahoo.com - January 30 at 8:28 AM
finance.yahoo.com logoMorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability
finance.yahoo.com - January 30 at 8:28 AM
seekingalpha.com logoMorphoSys: Positive Pelabresib Data Finally Unlocking Upside
seekingalpha.com - January 18 at 11:36 AM
markets.businessinsider.com logoEQS-News: MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference
markets.businessinsider.com - January 8 at 7:46 AM
finance.yahoo.com logoMorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 8 at 7:46 AM
finance.yahoo.com logoOptimistic Investors Push MorphoSys AG (ETR:MOR) Shares Up 48% But Growth Is Lacking
finance.yahoo.com - December 18 at 12:17 AM
markets.businessinsider.com logoMorphoSys To Issue 3.423 Mln New Shares At EUR 30/shr
markets.businessinsider.com - December 14 at 7:27 AM
marketwatch.com logoMorphoSys Shares Fall After Raising Funds to Accelerate Drug Launch, Trials
marketwatch.com - December 14 at 7:27 AM
markets.businessinsider.com logoEQS-Adhoc: Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process
markets.businessinsider.com - December 13 at 5:22 PM
markets.businessinsider.com logoBuy Rating on Morphosys Ag Backed by Pelabresib’s Breakthrough Efficacy in Myelofibrosis Treatment
markets.businessinsider.com - December 12 at 7:44 AM
markets.businessinsider.com logoBuy Rating on Morphosys Ag Backed by Strong MANIFEST-2 Trial Results and FDA Approval Potential
markets.businessinsider.com - December 11 at 8:02 PM
msn.com logoMorphoSys climbs after late-stage data for blood cancer therapy
msn.com - December 11 at 3:02 PM
markets.businessinsider.com logoMorphoSys : Pelabresib Improves All Four Hallmarks Of Myelofibrosis In Phase 3 Study
markets.businessinsider.com - December 11 at 12:17 AM
msn.com logoMorphosys AG - ADR (MOR) Price Target Increased by 86.05% to 16.88
msn.com - November 27 at 6:44 PM
markets.businessinsider.com logoWhy Is Cancer Focused MorphoSys Stock Trading Lower Today?
markets.businessinsider.com - November 21 at 1:49 PM
marketwatch.com logoStocks to Watch: Symbotic, MorphoSys, Agilent Technologies
marketwatch.com - November 20 at 7:14 PM
seekingalpha.com logoMorphoSys: Buying Constellation Was A Desperate Measure
seekingalpha.com - November 20 at 2:14 PM
msn.com logoMorphoSys GAAP EPS of -€3.50, revenue of €63.8M
msn.com - November 15 at 6:52 PM
msn.com logoI-Mab and HI-Bio gain breakthrough therapy designation for PMN therapy
msn.com - November 3 at 3:31 PM
finanznachrichten.de logoMorphoSys AG: MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
finanznachrichten.de - November 2 at 1:01 PM
finance.yahoo.com logoMorphoSys AG (MOR.VI)
finance.yahoo.com - October 26 at 12:36 AM
markets.businessinsider.com logoEQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
markets.businessinsider.com - October 25 at 9:34 AM
msn.com logoMorphosys AG - ADR (MOR) Price Target Increased by 288.42% to 11.98
msn.com - October 4 at 9:58 PM
Get MorphoSys News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOR and its competitors with MarketBeat's FREE daily newsletter.

A new way to collect income from stocks (Ad)

Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…

Click here to see me place one of these trades LIVE on camera.

MOR Media Mentions By Week

MOR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MOR
News Sentiment

0.91

0.43

Average
Medical
News Sentiment

MOR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MOR Articles
This Week

1

1

MOR Articles
Average Week

Get MorphoSys News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (ETR:MOR) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners